PrecisionPhage raises €2.2 million in seed funding

PrecisionPhage raised €1 million from Nordic Science Investment, Genetricum and Unifund and secured €1.2 million in Deep Tech Accelerator funding from Business Finland, a €2.2 million seed round. The company develops bioinformatic tools for phage analysis in research and production, licenses phages against common drug-resistant pathogens and offers phage laboratory services.